Not only is there insulin resistance in T2DM, but there is also a loss of the early phase insulin secretion leading to persistent hyperglycemia secondary to the inability to suppress both glucagon secretion and hepatic glucose output. This evidence concerns the gene GCG and Insulin resistance.